Phase 2 Prodromal Alzheimer's Disease Clinical Trials
3 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–3 of 3 trials
Recruiting
Phase 1Phase 2
A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)
Beta-AmyloidProdromal Alzheimer's DiseaseAmyloid Plaque+1 more
AC Immune SA176 enrolled19 locationsNCT05462106
Completed
Phase 2
A Phase II Extension study to assess the safety and tolerability of PBT2 and its effect on amyloid levels in the brains of patients with prodromal or mild Alzheimer's disease.
Prodromal Alzheimer's disease or mild Alzheimer's disease
Alterity Therapeutics40 enrolled3 locationsACTRN12613000777796
Completed
Phase 2
A Phase II clinical trial to assess the safety and tolerability of PBT2 and its effect on amyloid levels in the brains of patients with prodromal or mild Alzheimer's disease.
Prodromal Alzheimer's disease or mild Alzheimer's disease
Alterity Therapeutics42 enrolled5 locationsACTRN12611001008910